|Bid||23.45 x 900|
|Ask||26.06 x 1000|
|Day's Range||25.65 - 27.21|
|52 Week Range||19.08 - 36.15|
|Beta (5Y Monthly)||1.25|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 08, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||33.75|
Quanterix Corporation to Release Fourth Quarter 2019 Financial Results on March 9, 2020 and Present at Multiple Upcoming Healthcare Conferences
New CARE Consortium study applies ultra-sensitive biomarker solution to validate serum markers as objective indicators of mild traumatic brain injury.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
If you're interested in Quanterix Corporation (NASDAQ:QTRX), then you might want to consider its beta (a measure of...
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...